Year |
Citation |
Score |
2017 |
Habib M, Buisson M, Lupo J, Agbalika F, Socié G, Germi R, Baccard M, Imbert-Marcille BM, Dantal J, Morand P, Drouet E. Lytic EBV infection investigated by detection of Soluble Epstein-Barr virus ZEBRA in the serum of patients with PTLD. Scientific Reports. 7: 10479. PMID 28874674 DOI: 10.1038/S41598-017-09798-7 |
0.381 |
|
2016 |
Yabukarksi F, Leyrat C, Martinez N, Communie G, Ivanov I, Ribeiro EA, Buisson M, Gerard FC, Bourhis JM, Jensen MR, Bernadó P, Blackledge M, Jamin M. Ensemble Structure of the Highly Flexible Complex Formed between Vesicular Stomatitis Virus Unassembled Nucleoprotein and its Phosphoprotein Chaperone. Journal of Molecular Biology. PMID 27107640 DOI: 10.1016/J.Jmb.2016.04.010 |
0.357 |
|
2015 |
Thierry E, Brennich M, Round A, Buisson M, Burmeister WP, Hutin S. Production and characterisation of Epstein-Barr virus helicase-primase complex and its accessory protein BBLF2/3. Virus Genes. 51: 171-81. PMID 26292944 DOI: 10.1007/S11262-015-1233-6 |
0.367 |
|
2015 |
Burmeister WP, Buisson M, Estrozi LF, Schoehn G, Billet O, Hannas Z, Sigoillot C, Poulet H. Structure determination of feline calicivirus virus-like particles in the context of a pseudo-octahedral arrangement. Plos One. 10: e0119289. PMID 25794153 DOI: 10.1371/Journal.Pone.0119289 |
0.41 |
|
2012 |
Horst D, Burmeister WP, Boer IG, van Leeuwen D, Buisson M, Gorbalenya AE, Wiertz EJ, Ressing ME. The "Bridge" in the Epstein-Barr virus alkaline exonuclease protein BGLF5 contributes to shutoff activity during productive infection. Journal of Virology. 86: 9175-87. PMID 22696660 DOI: 10.1128/Jvi.00309-12 |
0.429 |
|
2012 |
Lupo J, Germi R, Semenova T, Buisson M, Seigneurin JM, Morand P. Performance of two commercially available automated immunoassays for the determination of Epstein-Barr virus serological status. Clinical and Vaccine Immunology : Cvi. 19: 929-34. PMID 22539474 DOI: 10.1128/Cvi.00100-12 |
0.39 |
|
2011 |
van Gent M, Griffin BD, Berkhoff EG, van Leeuwen D, Boer IG, Buisson M, Hartgers FC, Burmeister WP, Wiertz EJ, Ressing ME. EBV lytic-phase protein BGLF5 contributes to TLR9 downregulation during productive infection. Journal of Immunology (Baltimore, Md. : 1950). 186: 1694-702. PMID 21191071 DOI: 10.4049/Jimmunol.0903120 |
0.351 |
|
2009 |
Larrat S, Morand P, Bas A, Vigne S, Crance JM, Boyer V, Nicod S, Grossi L, Buisson M, Burmeister WP, Seigneurin JM, Germi R. Inhibition of Epstein-Barr virus replication by small interfering RNA targeting the Epstein-Barr virus protease gene. Antiviral Therapy. 14: 655-62. PMID 19704168 |
0.66 |
|
2009 |
Freeman L, Buisson M, Tarbouriech N, Van der Heyden A, Labbé P, Burmeister WP. The flexible motif V of Epstein-Barr virus deoxyuridine 5'-triphosphate pyrophosphatase is essential for catalysis. The Journal of Biological Chemistry. 284: 25280-9. PMID 19586911 DOI: 10.1074/Jbc.M109.019315 |
0.397 |
|
2009 |
Buisson M, Géoui T, Flot D, Tarbouriech N, Ressing ME, Wiertz EJ, Burmeister WP. A bridge crosses the active-site canyon of the Epstein-Barr virus nuclease with DNase and RNase activities. Journal of Molecular Biology. 391: 717-28. PMID 19538972 DOI: 10.1016/J.Jmb.2009.06.034 |
0.441 |
|
2007 |
Géoui T, Buisson M, Tarbouriech N, Burmeister WP. New insights on the role of the gamma-herpesvirus uracil-DNA glycosylase leucine loop revealed by the structure of the Epstein-Barr virus enzyme in complex with an inhibitor protein. Journal of Molecular Biology. 366: 117-31. PMID 17157317 DOI: 10.1016/J.Jmb.2006.11.007 |
0.4 |
|
2006 |
Buisson M, Rivail L, Hernandez JF, Jamin M, Martinez J, Ruigrok RW, Burmeister WP. Kinetics, inhibition and oligomerization of Epstein-Barr virus protease. Febs Letters. 580: 6570-8. PMID 17118362 DOI: 10.1016/J.Febslet.2006.11.006 |
0.426 |
|
2006 |
Tarbouriech N, Buisson M, Géoui T, Daenke S, Cusack S, Burmeister WP. Structural genomics of the Epstein-Barr virus. Acta Crystallographica. Section D, Biological Crystallography. 62: 1276-85. PMID 17001105 DOI: 10.1107/S0907444906030034 |
0.374 |
|
2005 |
Tarbouriech N, Buisson M, Seigneurin JM, Cusack S, Burmeister WP. The monomeric dUTPase from Epstein-Barr virus mimics trimeric dUTPases. Structure (London, England : 1993). 13: 1299-310. PMID 16154087 DOI: 10.1016/J.Str.2005.06.009 |
0.651 |
|
2002 |
Buisson M, Hernandez JF, Lascoux D, Schoehn G, Forest E, Arlaud G, Seigneurin JM, Ruigrok RW, Burmeister WP. The crystal structure of the Epstein-Barr virus protease shows rearrangement of the processed C terminus. Journal of Molecular Biology. 324: 89-103. PMID 12421561 DOI: 10.1016/S0022-2836(02)01040-9 |
0.638 |
|
2002 |
Challine D, Buisson M, Cadilhac M, Germanidis G, Joab I, Eliaszewicz M, Caumes E, Flahault A, Fillet AM, Pawlotsky JM, Seigneurin JM. Hepatitis C virus-Epstein-Barr virus interaction in patients with AIDS. Journal of Medical Virology. 67: 510-5. PMID 12115996 DOI: 10.1002/Jmv.10130 |
0.652 |
|
2002 |
Brengel-Pesce K, Morand P, Schmuck A, Bourgeat MJ, Buisson M, Barguès G, Bouzid M, Seigneurin JM. Routine use of real-time quantitative PCR for laboratory diagnosis of Epstein-Barr virus infections. Journal of Medical Virology. 66: 360-9. PMID 11793388 DOI: 10.1002/Jmv.2153 |
0.643 |
|
2002 |
Burmeister WP, Buisson M, Ruigrok RWH, Hernandez J, Arlaud G, Lascoux D, Forest E, Seigneurin J. Crystal structure of the Epstein-Barr virus protease Acta Crystallographica Section a Foundations of Crystallography. 58: c285-c285. DOI: 10.1107/S010876730209637X |
0.657 |
|
2001 |
Buisson M, Valette E, Hernandez JF, Baudin F, Ebel C, Morand P, Seigneurin JM, Arlaud GJ, Ruigrok RW. Functional determinants of the Epstein-Barr virus protease. Journal of Molecular Biology. 311: 217-28. PMID 11469870 DOI: 10.1006/Jmbi.2001.4854 |
0.669 |
|
1999 |
Morand P, Buisson M, Collandre H, Chanzy B, Genoulaz O, Bourgeat M, Pinel N, Leclercq P, Leroux D, Marechal V, Fritsch L, Ruigrok R, Seigneurin J. Human herpesvirus 8 and Epstein Barr-virus in a cutaneous B-cell lymphoma and a malignant cell line established from the blood of an AIDS patient. Leukemia & Lymphoma. 35: 379-387. PMID 10706463 DOI: 10.3109/10428199909145743 |
0.653 |
|
1999 |
Buisson M, Fleurent B, Mak M, Morand P, Chan L, Ng A, Guan M, Chin D, Seigneurin JM. Novel immunoblot assay using four recombinant antigens for diagnosis of Epstein-Barr virus primary infection and reactivation. Journal of Clinical Microbiology. 37: 2709-2714. PMID 10405428 DOI: 10.1128/Jcm.37.8.2709-2714.1999 |
0.422 |
|
1999 |
Buisson M, Morand P, Peoc'h M, Bouchard O, Bourgeat MJ, Seigneurin JM. Development of an Epstein-Barr virus type 2 (EBV-2)-associated hepatic B cell non-Hodgkin's lymphoma in an HIV-1-infected patient following a change in the EBV dominant type. Leukemia. 13: 298-301. PMID 10025906 DOI: 10.1038/Sj.Leu.2401268 |
0.483 |
|
1999 |
Bouzid M, Buisson M, Morand P, Perron H, Seigneurin J-. Different distribution of H1‐H2 Epstein‐Barr virus variant in oropharyngeal virus and in biopsies of Hodgkin's disease and in nasopharyngeal carcinoma from Algeria. Int. J. Cancer 77, 205–210 (1998) International Journal of Cancer. 80: 485-485. DOI: 10.1002/(Sici)1097-0215(19990129)80:3<485::Aid-Ijc24>3.0.Co;2-S |
0.636 |
|
1998 |
Bouzid M, Sheng W, Buisson M, Bouguermouh A, Morand P, Seigneurin JM, Ooka T. Different distribution of H1-H2 Epstein-Barr virus variant in oropharyngeal virus and in biopsies of Hodgkin's disease and in nasopharyngeal carcinoma from Algeria. International Journal of Cancer. 77: 205-10. PMID 9650553 DOI: 10.1002/(Sici)1097-0215(19980717)77:2<205::Aid-Ijc6>3.0.Co;2-U |
0.64 |
|
1998 |
Bouchard O, Buisson M, Morand P, Ledercq P, Seigneurin J. Évaluation de la réactivation du virus Epstein-Barr par méthode de PCR chez les patients infectés par le VIH La Revue De MéDecine Interne. 19: 66S. DOI: 10.1016/S0248-8663(98)80060-X |
0.642 |
|
1994 |
Buisson M, Morand P, Genoulaz O, Bourgeat M, Micoud M, Seigneurin J. Changes in the dominant Epstein-Barr virus type during human immunodeficiency virus infection Journal of General Virology. 75: 431-437. PMID 8113767 DOI: 10.1099/0022-1317-75-2-431 |
0.67 |
|
Show low-probability matches. |